Download presentation
Presentation is loading. Please wait.
Published byWendy Todd Modified over 6 years ago
1
It's not what you know, but who you know: Risk factors for re-infection in the Philadelphia High School STD Screening Program Jennifer Beck, MPH APHA Annual Meeting November 5, 2007
2
Outline Scope of the Problem: (Chlamydia) CT and (Gonorrhea) GC
Philadelphia High School STD Screening Program (PHSSSP) Introduction Research Design and Methods Results and Discussion Conclusions and Recommendations
3
Study Objective Identify and analyze risk factors associated with CT or GC re-infection within the same school year among high school students screened by the Philadelphia Department of Public Health (PDPH) STD Control Program
4
Scope of the Problem Source: PDPH 2007
C. trachomatis 976,445 cases in N. gonorrhoeae 300,000+ reported each year 7 CT and GC infections are largely asymptomatic Medical Outcomes include: pelvic inflammatory disease (PID), ectopic pregnancy, and other pregnancy related complications in females and infertility in both males and females 21 Source: PDPH 2007
5
Adolescent Re-infection Risk
35%-60% of re-infection occurs within the first four months Re-infection rates are highest in adolescent females and CT rates can range between 20% - 58% Researchers speculate why these rates are so high in this population Anatomy Immaturity (behavioral) Risky behavior (Schillinger et al, 2003; Niccolai et al, 2007 ) Why rates are so high: anatomical differences that increase susceptibility – and part of the risky behavior is lack of power (or perceived lack of power) to negotiate safe sex with partners.
6
Introduction to PHSSSP
Philadelphia High School STD Screening Program (PHSSSP) Began in school year to address high rates of GC and CT among adolescents. Educational session followed by voluntary screening PHSSSP consists of an educational session and a CT and GC screening The educational sessions covers basic information about STDs, consequences of untreated STDs and how they are acquired Students voluntarily screen and all information is confidential Urine specimens are collected from students who wish to be screened – NAAT screening of urine
7
Introduction to PHSSSP, Con.
In the second year of PHSSSP: Re-screening program initiated: Active follow-up for students with an initial positive test 3-6 months after treatment to detect re-infections in the same school year Disease Intervention Specialist (DIS) partner follow-up initiated: DIS interview those who are treated in the school or in the STD clinic to elicit the names and locating information of sex partners for follow-up
8
PHSSSP – The First 4 Years
Table 1. Summary of the first 4 years No. of Students School Year Screened 69,035 Positive 3308 (4.80%) Treated 3289 (99.4%) For the following analyses, year 1 data was excluded because no partner treatment, no retesting, no interviews
9
Research Methods and Design
All secondary data from PHSSSP Microsoft Access 2003 and SAS version 9.1 were used Univariate analyses and multi-variable analyses P-value of ≤ 0.05 as a significant value 95% Confidence Limits
10
Total included with a retest by eligibility
948 (42.8%) Tested after March 1st 1269 (57.2%) Eligible for Retest 2217 (93.5%) Initial Positives 645 (50.8%) Not Located for Retest 624 (59.2%) Valid Retests 49 (7.90%) Retests without interviews 575 (25.9%) Retests included Inclusion factors: Aged 12 – 20 years old Attended one of the schools included in the PHSSSP Lived within Philadelphia limits Had a positive urine screen for CT and/or GC Had an interview file from their initial positive screening School years: (“Year 2”), (“Year 3”), and (“Year 4”) Had a to have retested in the same school year of the initial positive test with PHSSSP Verification of treatment for initial positive Eligible for a retest (tested prior to March 1st of the school year) Present in school the day PDPH staff returned for the retest in order to provide urine specimen
11
Candidate Risk Factors
Gender Self-reported race/ethnicity Dual infection at first test Partner(s) treatment status School year School type Grade Age at initial test (continuous) Age group (categorical) Time to retest Residential ZIP code reported incidence
12
Main Study Variable: Partners’ Treatment Status
Table 2. Variable Categories Did students with an initial positive screen name partners? Were these partners treated by PDPH? Group # No N/A 1 Yes Yes, all were treated Yes, but only some were treated No, none were treated 2 The variable Partner(s) treatment status consisted of 4 possibilities categorized in 2 groups:
13
Results ~ 49,322 students were screened in years 2,3, and 4
2269 (4.6%) students with an initial positive test 52 exclusions 624 Retests 575 met inclusion criteria (49 missing interview files) The re-infection rate within the same school year was 13.6% (78 out of 575)
14
Results, Con. Risk of re-infection: Positive retests by gender and partner(s) treatment status
* This group includes at least some or all partners treated and no partners named Figure 3. *having untreated named partners is strongly associated with increased risk in females but not males.
15
Table 3. Retest positives by gender and partner(s) treatment status
Results Table 3. Retest positives by gender and partner(s) treatment status Female RR (95% C.L.) Male RR (95% C.L) Other 1.00 (ref) 1.08 (0.638, 1.83) None treated 2.20 (1.32, 3.65) 1.31 (0.355, 4.83) *Other includes at least some or all partners treated and no partners named
16
Conclusions and Recommendations
Naming sexual partners and having them treated by the PDPH is key to reducing re-infection rates among the students in PHSSSP, especially among females Males are most likely infecting females and should be retested as well. Recommendations include adding an educational component on re-infection to the existing educational presentation
17
Acknowledgements Philadelphia Department of Public Health, Division of Disease Control, STD Control Vic Spain, DVM, PhD Melinda E. Salmon Greta Anschuetz, MPH Martin Goldberg
18
Contact Information Phone: For more information about the PHSSSP contact Melinda Salmon: Phone:
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.